Adhera Therapeutics Inc ATRX:OTCPK

*Data is delayed | Exchange | USD
Last | 04/24/24 EDT
0.0075quote price arrow up+0.0008 (+11.791%)
Volume
2,001
52 week range
0.01 - 0.60
Loading...
  • Open0.0075
  • Day High0.0075
  • Day Low0.0075
  • Prev Close0.0075
  • 52 Week High0.60
  • 52 Week High Date04/25/23
  • 52 Week Low0.01
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap54,084.543
  • Shares Out7.22M
  • 10 Day Average Volume55,051.11
  • Dividend-
  • Dividend Yield-
  • Beta0.05
  • YTD % Change-75.03

KEY STATS

  • Open0.0075
  • Day High0.0075
  • Day Low0.0075
  • Prev Close0.0075
  • 52 Week High0.60
  • 52 Week High Date04/25/23
  • 52 Week Low0.01
  • 52 Week Low Date04/19/24
  • Market Cap54,084.543
  • Shares Out7.22M
  • 10 Day Average Volume55,051.11
  • Dividend-
  • Dividend Yield-
  • Beta0.05
  • YTD % Change-75.03

RATIOS/PROFITABILITY

  • EPS (TTM)-1.24
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.279M
  • ROE (TTM)-3,578.88%
  • Revenue (TTM)-
  • Gross Margin (TTM)20.45%
  • Net Margin (TTM)-5,581.06%
  • Debt To Equity (MRQ)-41.15%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adhera Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Adhera Therapeutics, Inc. is a specialty biotech company. The Company is focused on the drug development and commercialization of small molecule drugs to treat Parkinson's disease (PD) and Type 1 diabetes. The Company's advanced development programs are MLR-1019, a small molecule drug candidate being developed for PD, and MLR-1023, being developed to treat Type 1 diabetes. MLR-1019 is a highly selective dopamine re-uptake inhibitor for treating the dyskinesias associated with...
Andrew Kucharchuk
Vice Chairman of the Board, Acting Chief Financial Officer, Chief Operating Officer, Chief Business Officer
Address
P.O. Box 2161
Wake Forest, NC
27588
United States

Top Peers

SYMBOLLASTCHG%CHG
HGENQ
Humanigen Inc
0.0067UNCHUNCH
INBS
Intelligent Bio Solutions Inc
2.57UNCHUNCH
KLDO
Kaleido Biosciences Inc
0.0001UNCHUNCH
PHASQ
PhaseBio Pharmaceuticals Inc
0.00UNCHUNCH
GMDAQ
Gamida Cell Ltd
0.0155+0.0004+2.649%